234 related articles for article (PubMed ID: 12428799)
1. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
Lae ME; Ahmed I; Macon WR
Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
[TBL] [Abstract][Full Text] [Related]
2. Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms.
Nascimento AF; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 May; 121(5):709-17. PubMed ID: 15151211
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
[TBL] [Abstract][Full Text] [Related]
5. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
6. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
Fan G; Kotylo P; Neiman RS; Braziel RM
Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
[TBL] [Abstract][Full Text] [Related]
8. Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.
Chuang SS; Hsieh YC; Ye H; Hwang WS
Pathol Res Pract; 2009; 205(4):283-7. PubMed ID: 19091487
[TBL] [Abstract][Full Text] [Related]
9. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
10. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
12. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P
Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224
[TBL] [Abstract][Full Text] [Related]
13. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
14. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
15. The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas.
Bovio IM; Allan RW
Am J Clin Pathol; 2008 Oct; 130(4):628-34. PubMed ID: 18794057
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous anaplastic large cell lymphomas: a report of 9 cases from Thailand.
Eimpunth S; Sittinamsuwan P; Pattanaprichakul P; Silpa-archa N; Sethabutra P; Chularojanamontri L; Hanamornroongruang S; Mahaisavariya P
J Med Assoc Thai; 2012 Mar; 95(3):437-43. PubMed ID: 22550845
[TBL] [Abstract][Full Text] [Related]
17. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.
Lazzeri D; Agostini T; Bocci G; Giannotti G; Fanelli G; Naccarato AG; Danesi R; Tuccori M; Pantaloni M; D'Aniello C
Clin Breast Cancer; 2011 Oct; 11(5):283-96. PubMed ID: 21729665
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
[TBL] [Abstract][Full Text] [Related]
19. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
